| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Imeik Technology Development Co.Ltd (SHE: 300896)
300896 Technical Analysis
5
| As on 13th May 2025 300896 STOCK Price closed @ 171.50 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 244.69 & Strong Sell for SHORT-TERM with Stoploss of 301.85 we also expect STOCK to react on Following IMPORTANT LEVELS. |
300896STOCK Price
| Open | 174.11 | Change | Price | % |
| High | 174.49 | 1 Day | -1.42 | -0.82 |
| Low | 171.28 | 1 Week | -3.50 | -2.00 |
| Close | 171.50 | 1 Month | -15.18 | -8.13 |
| Volume | 2306627 | 1 Year | -159.70 | -48.22 |
| 52 Week High 352.91 | 52 Week Low 134.05 | ||||
SHE China Most Active Stocks
| 002640 | 4.60 | 0.88% |
| 002471 | 4.20 | 1.20% |
| 000559 | 9.74 | 4.96% |
| 002195 | 5.82 | -2.51% |
| 000725 | 3.92 | -0.25% |
| 002131 | 3.83 | -1.29% |
| 300059 | 21.45 | -1.24% |
| 000981 | 1.96 | -1.51% |
| 002475 | 33.80 | -0.94% |
| 000627 | 2.74 | -9.87% |
SHE China Top Gainers Stocks
SHE China Top Losers Stocks
| 300896 Daily Charts |
300896 Intraday Charts |
Whats New @ Bazaartrend |
300896 Free Analysis |
|
|
300896 Important Levels Intraday
| RESISTANCE | 177.69 |
| RESISTANCE | 175.70 |
| RESISTANCE | 174.48 |
| RESISTANCE | 173.25 |
| SUPPORT | 169.75 |
| SUPPORT | 168.52 |
| SUPPORT | 167.30 |
| SUPPORT | 165.31 |
300896 Forecast May 2025
| 4th UP Forecast | 301.67 |
| 3rd UP Forecast | 259.92 |
| 2nd UP Forecast | 234.12 |
| 1st UP Forecast | 208.31 |
| 1st DOWN Forecast | 134.69 |
| 2nd DOWN Forecast | 108.88 |
| 3rd DOWN Forecast | 83.08 |
| 4th DOWN Forecast | 41.33 |
300896 Weekly Forecast
| 4th UP Forecast | 205.32 |
| 3rd UP Forecast | 194.47 |
| 2nd UP Forecast | 187.77 |
| 1st UP Forecast | 181.06 |
| 1st DOWN Forecast | 161.94 |
| 2nd DOWN Forecast | 155.23 |
| 3rd DOWN Forecast | 148.53 |
| 4th DOWN Forecast | 137.68 |
300896 Forecast2025
| 4th UP Forecast | 605.44 |
| 3rd UP Forecast | 466.27 |
| 2nd UP Forecast | 380.25 |
| 1st UP Forecast | 294.23 |
| 1st DOWN Forecast | 48.77 |
| 2nd DOWN Forecast | -37.25 |
| 3rd DOWN Forecast | -123.27 |
| 4th DOWN Forecast | -262.44 |
Imeik Technology Development Co.Ltd ( SHE China Symbol : 300896 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
300896 Business Profile
Imeik Technology Development Co.,Ltd focuses on the research and development, manufacture, and sale of biomedical materials. It offers EME and Bonita that are indicated for injection into the deep dermis to the subcutaneous shallow for the correction of moderate to severe wrinkles of forehead and nasolabial area; IFRESH, which is indicated for injection into mid to deep dermis for the correction of moderate to severe nasolabial folds; Hearty that is indicated for injection into dermis for the correction of moderate to severe neck wrinkles; masks for various skin types; and syringe gun for intradermal injection indication. The company was founded in 2004 and is based in Beijing, China. Address: Shimao Building, Beijing, China, 100022
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service